We want to get the most out of every moment. Our purpose is to invigorate life, even through challenging times.
Now more than ever, we are focusing on what really matters. Checking in on neighbors, sharing the latest scientific information, video chatting with family, friends, and colleagues—our society has stepped up in an extraordinary way to support one another. It seems the best of us emerges during the toughest of times.
I feel very fortunate to work at a company whose product can help us support our cellular health—which is health at the most foundational level. Tru Niagen® supports your levels of NAD+, which is critical to generating energy within the trillions of cells throughout your body. These levels decline not only with age but also with physiological stress on your body. Without NAD+, your cells can't function properly, and neither can you.
The science behind NAD+, Niagen®, and cellular health continues to grow at an unparalleled rate. That is why I send Tru Niagen® to my loved ones, and I encourage the Tru Niagen® community to share the science as well.
To your health,
Our Journey In Science
1999 - ChromaDex is founded
Relationships with leading universities and institutions built the pillars of ChromaDex. Powered by business, ChromaDex further accelerates research by discovering and licensing early-stage, IP-backed ingredient technologies.
2004 - Dr. Brenner’s discovery
Dr. Charles Brenner discovers nicotinamide riboside could support levels of a cellular resource called NAD+, a vital function in cellular health.
2012 - ChromaDex and Dr. Brenner
ChromaDex exclusively licenses the patents behind Dr. Brenner’s research, forging a path to make this revolutionary science available to the world.
2013 - Niagen® is born
ChromaDex continues to build a strong patent portfolio around nicotinamide riboside and commercializes the ingredient as Niagen®.
2015 - FDA NDI
Niagen® is successfully reviewed under the FDA’s New Dietary Ingredient (NDI) notification program.
2016 - FDA GRAS
Niagen is successfully notified to FDA.
2017 - Tru Niagen® launches in the United States
ChromaDex acquires Healthspan Research, LLC and sells Tru Niagen® products to consumers.
2018 - Tru Niagen® receives approval from Health Canada
ChromaDex receives regulatory approval to sell Tru Niagen® in Canada.
2019 - Australian Therapeutic Goods Administration (TGA) Approval
TGA approves nicotinamide riboside chloride (NR) ingredient as a complementary medicine in Australia.
2020 - Ten clinical studies and European Commission Approval
Niagen® has been studied in ten published human trials that demonstrate its efficacy in supporting NAD+.
European Commission votes in favor on nicotinamide riboside chloride (NR) ingredient as a novel food, following the 2019 positive opinion from EFSA.